Additionally, A3C expression was assessed by RT–qPCR in whole blood samples obtained from a cohort of 12 GBM patients and 12 healthy controls, with significantly higher expression found in the GBM patients than in the controls (Figure 8C). This evidence concerns the gene APOBEC3C and glioblastoma.